General MedicationsORALStandard
DASATINIB
DASATINIB
Standard Dose
140MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DASATINIB is listed in Drugs@FDA under application 218719 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DASATINIB Form and strength TABLET;ORAL - 140MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2025-03-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview DASATINIB is listed in Drugs@FDA under application 218719 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DASATINIB Form and strength TABLET;ORAL - 140MG Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2025-03-03 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.